- Professional electrophysiologist, high level experience in standard, 3d mapping, high density mapping, intracardiac echocardiographyedit
Research Interests:
Cardiac resynchronisation therapy has proven to be effective in refractory heart failure (HF) patients with QRS... more
Cardiac resynchronisation therapy has proven to be effective in refractory heart failure (HF) patients with QRS >120-130 ms. Therefore, the aim of our study was to verify the long-term effectiveness of cardiac resynchronisation therapy in HF patients with echocardiographic evidence of mechanical asynchrony regardless of QRS duration. One hundred and six patients with New York Heart Association class II-IV HF and echocardiographic documentation of interventricular and intraventricular asynchrony underwent biventricular stimulation. A clinical and functional evaluation was performed at baseline, 1, 3, 6 months, and every 6 months thereafter. After a median follow-up of 16 months, a significant improvement was noted in ejection fraction, left ventricular diameters, mitral regurgitation jet area, interventricular and intraventricular echocardiographic indexes of asynchrony, and the 6-min walking distance (P < 0.001 for all). Death rates for all causes and for cardiac causes were 18.2 (95% confidence interval 12.8-25.9) and 13.5 (95% confidence interval 9.0-20.3) per 100 person-years, respectively. Patients in New York Heart Association class IV had an almost three-fold increase in risk of dying as compared to class II-III (hazard ratio 2.97, 95% confidence interval 1.30-6.79). Interventricular and intraventricular asynchrony at echocardiography may be useful in identifying HF patients suitable for cardiac resynchronisation therapy, with results comparable to those obtained with QRS duration selection criteria.
Research Interests:
Research Interests:
Research Interests:
Heart Rhythm, Volume 2, Issue 5, Pages S99, May 2005, Authors:Giuseppe Ricciardi, MD; Rita Nistri, MD; Marzia Giaccardi, MD; Alessia Pappone, MD; Massimo Sassara, MD; Federico Turreni, MD; Augusto Achilli, MD; Luigi Padeletti, MD, PhD. ...
Research Interests:
Research Interests: Survival Analysis, Risk assessment, Comorbidity, Cardiac Surgery, Italy, and 17 moreHeart Failure, Humans, Female, Male, Risk factors, Left Ventricular Dysfunction, Registries, Clinical Sciences, Aged, Prevalence, Middle Aged, Longitudinal Studies, Survival Rate, Risk Factors, Risk Assessment, Arrhythmia, and Cardiac-Resynchronization-Therapy-Devices-Market
Syncope in patients with bifascicular block (BFB) is a common event whose causes might be difficult to assess. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRESS) is a multicenter,... more
Syncope in patients with bifascicular block (BFB) is a common event whose causes might be difficult to assess. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRESS) is a multicenter, prospective, randomized, single-blinded study designed to demonstrate a reduction in symptomatic events in patients with bifascicular block and syncope of undetermined origin implanted with permanent pacemaker. Device programming mode (NASPE/BPEG code) at DDD with a lower rate of 60 ppm is compared with backup pacing at DDI with a lower rate of 30 ppm. The end point consisted of (1) syncope, (2) symptomatic presyncopal episodes associated with a device intervention (ventricular pacing), and (3) symptomatic episodes associated with intermittent or permanent atrioventricular block (any degree). One hundred one patients were enrolled and randomized. Primary end point events at 2 years were observed in 23 patients, with a significant lower incidence in the study ...